AHANeurology2021
AHA/ASA Guideline for the Prevention of Stroke in Patients with Stroke and TIA 2021
Published by American Heart Association · 82 pages · Class I–III
21 daysDAPT duration
<130/80BP Target
Class IStatin
Summary
Free previewFocused update on secondary stroke prevention. Dual antiplatelet therapy (aspirin + clopidogrel or ticagrelor) for 21 days following minor stroke/high-risk TIA is Class I. Intracranial stenting not recommended for symptomatic patients on maximal medical therapy.
StrokeTIASecondary preventionDAPTAnticoagulationCarotid endarterectomy
Key Recommendations
Evidence Grading & Drug Doses
What's New vs Previous Version
Implementation & Clinical Pearls
Full guideline access requires an account
Create a free Prognia account to read the complete guideline — including all recommendations, evidence tables, drug dosing, and clinical pearls.
Full guideline text with all recommendations
Evidence grades (Class I/II/III, Level A/B/C)
AI-generated summary and clinical pearls
Auto-logged as CPD/CME activity
Free plan includes 10 guideline reads per day · No credit card required